Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2017
Price : $35 *
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms CAPolista
- 09 Aug 2017 Results published in the Vaccine
- 02 Jun 2015 Status changed from recruiting to completed as per Netherlands Trial Register.
- 22 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.